Danish biotech company receives 4.4 million EUR investment from the EU

Cysbiolab

The Danish biotech company, Cysbio, has received two grants from the EU’s “Horizon 2020” program worth 4.4 million euros. According to the management, it is ground-breaking research that has paved the way for these grants that will accelerate the development work and allow faster product introductions.